MC10 RESEARCH PEPTIDES COLLECTION
Need help?WhatsApp +44 7463 910127
RESEARCH PROFILES / MC10 RESEARCH

KPV: a short peptide with model-dependent findings

Three amino acids do not make the evidence simple.

Published 30 September 2026

Three amino acids do not make the evidence simple.

An alpha-MSH-derived sequence

KPV is a tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone. A study in immortalised human bronchial epithelial cells investigated responses to KPV and related melanocortin ligands. It examined inflammatory signalling in that model, not a treatment outcome in patients.

Model matters

Another experimental comparison found different results for KPV across its in-vivo and in-vitro endpoints. This is a useful reminder that cell type, pathway and conditions can change the interpretation. A blend that includes KPV also needs component-specific identity and amount data.

Research takeaway

Describe the measured endpoint and model rather than assigning a general health benefit to KPV.

Sources

Read the original studies or guidance for methods, populations and limitations.

This article is general research information. It is not a Certificate of Analysis for an MC10 product or medical advice. MC10 materials are presented for in-vitro research only.

Next article: NAD+ is in the catalogue, but it is not a peptide ↗